Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07390760 · ClinicalTrials.gov registry record · NA

Remote Ischemic Conditioning and Spinal Reflex Modulation in Children With Cerebral Palsy

A NA study of Children With Cerebral Palsy, sponsored by East Carolina University.

Recruiting
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT07390760: Recruiting NA study of Children With Cerebral Palsy, sponsored by East Carolina University.

NCT07390760 is a NA study of Children With Cerebral Palsy that is actively recruiting participants, run by East Carolina University. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07390760, a NA study of Children With Cerebral Palsy, is actively recruiting participants, sponsored by East Carolina University.

RECRUITING
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

Remote ischemic conditioning (RIC) is a clinically feasible intervention involving brief, sublethal periods of ischemia followed by reperfusion that has been shown to enhance motor performance, strength, and balance when combined with training in healthy adults and individuals with neurological conditions. Although RIC is thought to influence neuroplasticity through neural, metabolic, and humoral pathways, its effects on spinal-level mechanisms remain poorly understood. Emerging evidence indicates that neuroplastic adaptations occur not only at the cortical level but also within the spinal cord. Moreover, altered spinal reflex excitability is associated with spasticity, balance impairments, and functional limitations in children with cerebral palsy (CP), yet the role of spinal reflex modulations in response to RIC and balance training remains under expplored in this population. Therefore, this study aims to investigate the effects of RIC combined with balance training on spinal reflex modulation in children with CP.

Primary Outcome

The maximal (peak) H-reflex amplitude will be determined from the recruitment (stimulus-response) curve. The Hmax amplitude provides an estimate of the number or proportion of motor neurons (MNs) activated from the total MN pool, reflecting spinal reflex modulations and spinal neuroplasticity.

Interventions

  • BEHAVIORAL Remote Ischemic Condtioning (RIC)
  • BEHAVIORAL Sham conditioning
  • BEHAVIORAL Balance training

Study Locations (1)

North Carolina

  • East Carolina University - Greenville

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2025-07-28
Est. Completion 2026-12-31
Phase NA
East Carolina University

58 total trials

What NCT07390760 shows while recruiting

NCT07390760 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Children With Cerebral Palsy appearing as the primary indexed condition, and to 3 interventions - of which Remote Ischemic Condtioning (RIC) is the first listed.

NCT07390760 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT07390760 about?

NCT07390760 is a clinical study titled "Remote Ischemic Conditioning and Spinal Reflex Modulation in Children With Cerebral Palsy". Remote ischemic conditioning (RIC) is a clinically feasible intervention involving brief, sublethal periods of ischemia followed by reperfusion that has been shown to enhance motor performance, strength, and balance when combined with training in healthy adults and individuals with neurological cond...

What is the current status of trial NCT07390760?

This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2025-07-28. Estimated completion is 2026-12-31.

What conditions does trial NCT07390760 study?

This clinical trial studies the following conditions: Children With Cerebral Palsy.

What interventions are being tested in trial NCT07390760?

The interventions under investigation include: Remote Ischemic Condtioning (RIC) (BEHAVIORAL), Sham conditioning (BEHAVIORAL), Balance training (BEHAVIORAL).

Who is sponsoring clinical trial NCT07390760?

This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07390760 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT07390760's enrollment target sits among peer trials

16 1871st of 2000 higher than 120 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07390760, the US trial registry maintained by the National Library of Medicine. NCT07390760 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.